Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Roche
Pharma
Orphan drug market to reach $270B by 2028: Evaluate
The high-flying drug sector is set for a slight sales growth slowdown throughout the decade, according to Evaluate's 2024 Orphan Drug Report.
Zoey Becker
Apr 24, 2024 12:01am
Roche's Alecensa snags FDA postsurgery nod in lung cancer
Apr 19, 2024 11:03am
Roche touts near-complete MS suppression for injectable Ocrevus
Apr 17, 2024 11:00am
Roche eyes earlier treatment nod after Columvi-chemo trial win
Apr 15, 2024 11:36am
Top 20 pharma companies by 2023 revenue
Apr 15, 2024 3:00am
Enspryng falls short of Roche's expectations in myasthenia gravis
Mar 21, 2024 11:28am